The Vanderbilt Institute for Clinical and Translational Research (VICTR)

Tiie范德比尔特临床和转化研究所（VICTR）已成为一个充满活力的 以及临床和转化科学的培育基地。在四年中，卢旺达问题国际法庭已牢固地融入 进入范德比尔特，梅哈里财团提供了一个，重点加强临床和转化研究， 所有学科和创建，组织和提供临床和转化科学工具，方法， 资源和教育计划。我们精简了行政程序，并推广 CTSA的翻译精神。所追求的创新和改进使研究和 研究人员茁壮成长：去年，卢旺达问题国际法庭支持了600多名研究人员。通过支持， CTSA，所提供的服务已扩大，已被更频繁地使用，并已被用于 整个财团。这些服务已被范德比尔特内部的所有相关学科使用， Meharry和研究人员在他们职业生涯的每个阶段。我们更新建议的具体目标是： 1)系统地消除研究翻译的障碍; 2）创造和提供小说， 研究基础设施和资源; 3）培训下一代研究人员; 4）参与和 让当地社区参与进来; 5）定义并持续衡量实现目标的成功程度。 卢旺达问题国际法庭的一个目标是为国家CTSA联合会作出贡献，因为整个方案的成功 对于它的连续性和推动临床和转化的真实的社会影响都是至关重要的 科学我们将继续以多种方式作出贡献，包括积极为委员会服务， 在领导小组内，分享新的方法，继续发展和传播 软件和工具。在下一个资助周期中，VICTR团队将继续推动发现和想法 毫不拖延地通过光谱研究有效地转化为临床实践。 相关性（参见说明）：范德比尔特临床和转化研究所专注于去除 研究翻译的障碍，创建新的基础设施，培训新的C&T科学家， 并让当地社区参与到改善健康中来。卢旺达问题国际法庭为CJTSA联合会作出贡献，包括 软件和工具的开发和传播。在下一个赠款周期，卢旺达问题国际法庭将继续 推动发现和想法毫不拖延地通过研究的范围，以有效地转化为 临床实践

Tiie Vanderbilt Institute for Clinical and Translational Research (VICTR) has been established as a vibrant and nurturing home for clinical and translational science. In four years, VICTR has become firmly integrated into the Vanderbilt, Meharry Consortium providing a,focus for enhanced clinical and translational research for all disciplines and creating, organizing and making available clinical and translational science tools, methods, resources and educational programs. We have streamlined administrative processes and promoted the translational spirit ofthe CTSA. The innovations and improvements pursued have enabled both research and researchers to thrive: over 600 investigators were supported by VICTR last year. Through the support of the CTSA, the services offered have been expanded, have been used more frequently and have been used across the consortium. These services have been accessed by all relevant disciplines within Vanderbilt and Meharry and by researchers at every stage of their career. The specific aims of our renewal proposal are to: 1) Systematically remove impediments to research translation; 2) Create and make available novel, research-enabling infrastructure and resources; 3) Train the next generation of investigators; 4) Engage and involve the local community; and 5) Define and continuously measure success in meeting objectives. Contributing to the national CTSA consortium is an objective of VICTR, as the success of the entire program is essential both for its continuity, and for the real societal impact on propelling clinical and translational science. We will continue to contribute in a number of ways, including active service on committees and within the leadership group, sharing of novel methods, and continued development and dissemination of software and tools. In the next grant cycle the VICTR team will continue to propel discoveries and ideas without delay through the spectrum of research to effective translation into clinical practice. RELEVANCE (See instructions): Vanderbilt Institute for Clinical and Translational Research is focused on removing impediments to research translation, creating new infrastructure, training new C&T scientists, and engaging and involving the local community to improve health. VICTR contributes to the CJTSA consortium, including the development and dissemination of software and tools. In the next grant cycle VICTR will continue to propel discoveries and ideas without delay through the spectrum of research to effective translation into clinical practice.